https://peptide.global/ https://peptide.global/archive https://peptide.global/atlas https://peptide.global/about https://peptide.global/bay/deals https://peptide.global/bay/plants https://peptide.global/bay/process https://peptide.global/bay/trade https://peptide.global/story/torrent-semaglutide-brazil-launch-targeted-within-nine-months-but-the-maker-behind-it-is-u2026-10-25 https://peptide.global/story/gilead-pepstar-deal-buys-an-oral-il-23r-peptide-for-1-275-billion-with-no-plant-attached2026-10-25 https://peptide.global/story/semaglutide-patent-expiry-map-shows-copies-in-india-canada-and-brazil-while-china-waits-un2026-10-25 https://peptide.global/story/outbound-investment-biotech-rule-puts-us-stakes-in-chinese-biomanufacturing-plants-under-t2026-10-25 https://peptide.global/story/dr-reddys-semaglutide-restart-hangs-on-three-validation-batches-after-a-scale-up-impurity2026-10-25 https://peptide.global/story/sanofi-insulin-plant-in-frankfurt-breaks-ground-with-supply-duties-that-run-to-20422026-10-24 https://peptide.global/story/sri-lanka-insulin-factory-in-koggala-is-built-and-targets-first-output-in-20272026-10-24 https://peptide.global/story/ql-biopharm-wuxi-base-will-make-its-glp-1-peptides-with-an-e-coli-process2026-10-24 https://peptide.global/story/hybio-peptide-api-sales-lift-profit-fivefold-as-its-expansion-placement-lapses2026-10-24 https://peptide.global/story/mhra-counterfeit-weight-loss-pens-haul-in-birmingham-shows-illicit-packing-at-scale2026-10-24 https://peptide.global/story/samsung-biologics-polypeptide-tender-clears-its-bar-as-songdo-keeps-booking-biologics-work2026-10-23 https://peptide.global/story/dupont-amberchrom-sil-adds-reverse-phase-silica-to-peptide-purification-lines2026-10-23 https://peptide.global/story/fda-import-alert-shuts-out-two-chinese-glp-1-ingredient-plants2026-10-23 https://peptide.global/story/kilitch-drugs-ethiopia-sale-funds-a-new-pen-site-with-glp-1-on-the-plan2026-10-23 https://peptide.global/story/lilly-mubadala-bio-deal-adds-a-glp-1-packaging-stage-at-a-kezad-site-in-abu-dhabi2026-10-23 https://peptide.global/story/chinese-makers-line-up-semaglutide-copies-as-the-local-patent-nears-its-end2026-01-20 https://peptide.global/story/a-version-of-the-biosecure-act-passes-aimed-at-some-chinese-biotech-suppliers2025-12-18 https://peptide.global/story/us-announces-100-tariff-on-branded-drug-imports-with-a-plant-building-exemption2025-09-26 https://peptide.global/story/lillys-houston-plant-will-make-its-glp-1-pill-which-skips-peptide-chemistry2025-09-23 https://peptide.global/story/eu-and-us-agree-a-15-cap-that-covers-medicines2025-08-21 https://peptide.global/story/yeast-or-resin-the-two-ways-glp-1-peptides-get-made2025-06-10 https://peptide.global/story/bachems-big-new-peptide-building-in-bubendorf-starts-up-in-stages2025-04-24 https://peptide.global/story/why-one-kilo-of-peptide-drug-can-need-thousands-of-kilos-of-material2025-03-18 https://peptide.global/story/lilly-plans-four-more-us-plants-a-27-billion-step2025-02-26 https://peptide.global/story/catalent-deal-closes-three-fill-finish-plants-pass-to-novo-nordisk2024-12-18 https://peptide.global/story/novo-nordisk-to-spend-4-1-billion-on-a-fill-and-finish-plant-in-clayton-north-carolina2024-06-24 https://peptide.global/story/novo-nordisk-commits-dkk-42-billion-to-new-production-at-kalundborg2024-06-12 https://peptide.global/story/lilly-buys-an-injectables-plant-in-pleasant-prairie-wisconsin-from-nexus2024-06-04 https://peptide.global/story/lilly-lifts-its-lebanon-indiana-build-to-9-billion-to-make-tirzepatide-ingredient2024-05-14 https://peptide.global/story/cordenpharma-plans-about-900-million-to-grow-peptide-capacity-in-europe-and-the-us2024-02-20 https://peptide.global/story/lilly-picks-alzey-germany-for-a-2-5-billion-injectables-plant2023-11-17